Evidence map›Paper›PMID 26185263›Full record

Trial reportClinical journal of the American Society of Nephrology : CJASN2015

Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD.

Richard Solomon, Paul Gordon, Steven V Manoukian, J Dawn Abbott, Dean J Kereiakes, Allen Jeremias, Michael Kim, Harold L Dauerman, BOSS Trial Investigators

Open access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 5 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 5 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Low urine pH: a new marker for contrast-associated acute kidney injury?EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022
    Article
  9. Contrast-Associated Acute Kidney Injury.Journal of clinical medicine · 2022
    Review
  10. Article
  11. Observational
  12. Article
  13. Contrast-Induced Acute Kidney Injury: Review and Practical Update.Clinical Medicine Insights. Cardiology · 2019
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Richard SolomonDepartment of Medicine, University of Vermont Medical Center, Burlington, Vermont; Richard.solomon@vtmednet.org.
Paul GordonDivision of Cardiology, Miriam Hospital, Providence, Rhode Island;
Steven V ManoukianSarah Connon Research Institute, Hospital Corporation of America, Nashville, Tennessee;
J Dawn AbbottDivision of Cardiology, Rhode Island Hospital, Providence, Rhode Island;
Dean J KereiakesChrist Hospital Heart and Vascular Center, Lindner Research Center, Cincinnati, Ohio;
Allen JeremiasDivision of Cardiology, Stony Brook University Hospital, Stony Brook, New York; and.
Michael KimMount Sinai Hospital, New York City, New York.
Harold L DauermanDepartment of Medicine, University of Vermont Medical Center, Burlington, Vermont;
BOSS Trial Investigators
Christ Hospital · USHCA Healthcare · USMiriam Hospital · USMount Sinai Hospital · USRhode Island Hospital · USStony Brook University Hospital · USUniversity of Vermont Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesSodium bicarbonate has been proposed for protection of the kidney from contrast-induced AKI (CIAKI). However, the effects of bicarbonate on long-term important clinical outcomes are uncertain. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a prospective, double-blind, multicenter randomized clinical trial, 391 patients with an eGFR<45 ml/min per 1.73 m(2) undergoing elective coronary or peripheral angiography were randomized to an infusion with a high dose of isotonic sodium bicarbonate (target 2.0 mEq/kg) or a similar molar amount of isotonic sodium chloride. The primary outcome was a composite of mortality, dialysis, or a sustained 20% reduction in eGFR at 6 months.

resultsThere were 391 patients enrolled between March 2010 and May 2012. The incidence of the primary outcome was 14.9% in the bicarbonate group and 16.3% in the control group in the intention-to-treat population (P=0.78). There was also no difference in the incidence of CIAKI between the treatment groups (14.5% versus 12.1%, respectively; P=0.20). CIAKI was associated with a higher incidence of sustained loss of kidney function at 6 months compared with those without CIAKI (21.2% versus 7.7%, respectively; P=0.06).

conclusionsHigh-dose sodium bicarbonate infusion in patients with eGFR<45 ml/min per 1.73 m(2) undergoing angiography did not demonstrate a difference in incidence of the composite of death, dialysis, or sustained 6-month reduction in eGFR or CIAKI compared with sodium chloride.

Indexed as

Acute Kidney InjuryAgedAged, 80 and overContrast MediaCoronary AngiographyDouble-Blind MethodFemaleGlomerular Filtration RateHumansIntention to Treat AnalysisMaleMiddle AgedProspective StudiesRenal DialysisRenal Insufficiency, ChronicSodium BicarbonateContrast MediaSodium BicarbonateSodium Chlorideacute renal failurecoronary artery diseasedialysismortality

Identifiers

PMID26185263
PMCPMC4559510
OpenAlexW2123071874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.